Security key
29405E208
Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB)
CUSIP: 29405E208
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 489,047
- Total 13F value
- $635,757
- Share change
- +266,181
- SEC-reported price per share
- $1.30
- Number of holders
- 13
- Value change
- +$341,904
- Number of buys
- 4
- Number of sells
- 6
- Shares outstanding
- 1,022,530
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q4 2023
Institutions
13
Top holders
10
ENVB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Enveric Biosciences, Inc. SEC filings
Enveric Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29405E208
Recent filing periods:
Ownership snapshot
Top reported holders of ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AdvisorShares Investments...
Disclosed value leader
AdvisorShares Investments...
Comparable rows
14/15
Latest evidence
30 Sep 2023
13F
3/4/5
Lead comparable stake: 14%
1 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
AdvisorShares Investments LLC leads the comparable SEC ownership view at 14%.
14 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
AdvisorShares Investments LLC
14%
BlackRock Finance, Inc.
2.9%
VANGUARD GROUP INC
1.8%
GEODE CAPITAL MANAGEMENT, LLC
1.3%
Tower Research Capital LLC (TRC)
0.94%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC |
13F
Company
|
14%
|
$339,184
146,833 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
2.9%
|
$70,396
29,578 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
1.8%
|
$42,876
18,015 shares
|
— | 30 Sep 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.3%
|
$30,302
13,118 shares
|
— | 30 Sep 2023 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.94%
|
$22,898
9,621 shares
|
— | 30 Sep 2023 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
0.45%
|
$10,000
4,559 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
489,047
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
14
Q4 2023 holders
13
Holder diff
-1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend